Company / Return on Assets (ROA)
FENNEC PHARMACEUTICALS INC. Return on Assets (ROA) History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-0.6%
FY2025
5-year range
-88.3% / -0.6%
FY2021-FY2025
Trend
+98.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 10 years, ranging from -213.5% in FY2015 to 77.8% in FY2014.
Based on SEC 10-K filings.
-0.6% in FY2025 with a 10-year CAGR of +212.9%.
Improved from -88.3% to -0.6% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- +212.9pp
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 98.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2014.
- Lowest return on assets (roa) in the period was in FY2015.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -0.6% | +98.3% |
| FY2024 | -35.7% | +59.6% |
| FY2023 | -88.3% | -9.3% |
| FY2021 | -80.8% | -15.6% |
| FY2019 | -69.9% | -127.7% |
| FY2018 | -30.7% | -212.6% |
| FY2017 | -9.8% | +40.8% |
| FY2016 | -16.6% | +92.2% |
| FY2015 | -213.5% | -374.5% |
| FY2014 | 77.8% | +3786.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026